Investigation of nanoparticles using magnetic resonance imaging after intravitreal injection

Clinical and Experimental Ophthalmology

Volumn 40, Issue 1, 2012, Pages 100-107

  Raju, Hemalatha B ^a   Hu, Ying ^a   Padgett, Kyle R ^b   Rodriguez, Jose E ^c   Goldberg, Jeffrey L ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Radiology ^*  (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Imaging systems; Magnet; Nanoparticles; Toxicity

Indexed keywords

MAGNETIC NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; EYE; FEMALE; IN VIVO STUDY; INTRAVITREAL DRUG ADMINISTRATION; KIDNEY; LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SPLEEN; TOXICITY TESTING;

ANIMALS; CONTRAST MEDIA; FEMALE; FERROCYANIDES; INTRAVITREAL INJECTIONS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; RETINA; TISSUE DISTRIBUTION; VITREOUS BODY;

EID: 84856644745     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02651.x     Document Type: Article

References (22)

1. Boddu SH, Jwala J, Vaishya R etal. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocul Pharmacol Ther 2010; 26: 37-48.
2. de Kozak Y, Andrieux K, Villarroya H etal. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis. Eur J Immunol 2004; 34: 3702-12.
3. Cai X, Nash Z, Conley SM, Fliesler SJ, Cooper MJ, Naash MI. A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One 2009; 4: e5290.
4. Kim H, Csaky KG. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. J Control Release 2010; 142: 286-93.
5. Park K, Chen Y, Hu Y etal. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Diabetes 2009; 58: 1902-13.
6. Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther 2009; 16: 645-59.
7. Cai X, Conley SM, Nash Z, Fliesler SJ, Cooper MJ, Naash MI. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J 2010; 24: 1178-91.
8. Jeun M, Jeoung JW, Moon S etal. Engineered superparamagnetic Mn0.5Zn0.5Fe2O4 nanoparticles as a heat shock protein induction agent for ocular neuroprotection in glaucoma. Biomaterials 2011; 32: 387-94.
9. Prow T, Smith JN, Grebe R etal. Construction, gene delivery, and expression of DNA tethered nanoparticles. Mol Vis 2006; 12: 606-15.
10. Anderson SA, Rader RK, Westlin WF etal. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000; 44: 433-9.
11. Amsalem Y, Mardor Y, Feinberg MS etal. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007; 116: I38-45.
12. Callera F, de Melo CM. Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev 2007; 16: 461-6.
13. Guzman R, Uchida N, Bliss TM etal. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 2007; 104: 10211-6.
14. Raju HB, Hu Y, Vedula A, Dubovy SR, Goldberg JL. Evaluation of magnetic micro- and nanoparticle toxicity to ocular tissues. PLoS One 2011; 6: e17452.
15. Sha O, Kwong WH. Postnatal developmental changes of vitreous and lens volumes in Sprague-Dawley rats. Neuroembryol Aging 2006; 4: 183-8.
16. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 2008; 5: 316-27.
17. Kumar R, Roy I, Ohulchanskky TY etal. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010; 4: 699-708.
18. Galagudza MM, Korolev DV, Sonin DL etal. Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity. Int J Nanomedicine 2010; 5: 231-7.
19. Chen H, Wang L, Yeh J etal. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials 2010; 31: 5397-407.
20. Loebinger MR, Kyrtatos PG, Turmaine M etal. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009; 69: 8862-7.
21. Sykova E, Jendelova P. In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res 2007; 161: 367-83.
22. Lee IH, Bulte JW, Schweinhardt P etal. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol 2004; 187: 509-16.